N

Nektar Therapeutics
D

NKTR

0.60430
USD
-0.06
(-8.83%)
مغلق
حجم التداول
93,972
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
112,462,398
أصول ذات صلة
A
ALKS
-0.970
(-2.97%)
31.660 USD
AMGN
AMGN
4.42
(1.45%)
310.04 USD
BIIB
BIIB
-0.630
(-0.48%)
130.690 USD
BMRN
BMRN
-0.810
(-1.19%)
67.490 USD
GILD
GILD
0.450
(0.40%)
112.380 USD
INCY
INCY
0.180
(0.29%)
62.500 USD
LLY
LLY
-28.72
(-3.51%)
788.94 USD
MRK
MRK
-0.220
(-0.25%)
86.370 USD
PFE
PFE
-0.385
(-1.56%)
24.290 USD
REGN
REGN
-14.36
(-2.30%)
610.88 USD
المزيد
الأخبار المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.